Nicotine Dependence Completed Phase 2 Trials for Nicotine (DB00184)

Also known as: Nicotine dependence, unspecified / Nicotine addiction

IndicationStatusPhase
DBCOND0030647 (Nicotine Dependence)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00469079Health Effects of SLT, Cigarette Smoking, and New Tobacco ProductsTreatment
NCT02906644Combination Nicotine Patch / Lorcaserin for Smoking CessationTreatment
NCT00960778Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized CigarettesTreatment
NCT00105482Targeted Interventions for Weight-Concerned SmokersTreatment
NCT00956943Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of NicotineTreatment
NCT00996034Nicotine Vaccination and Nicotinic Receptor OccupancyHealth Services Research
NCT01280968Improving the Efficacy of Anti-Nicotine ImmunotherapyBasic Science
NCT01292642Cognitive Behavioral Therapy and the Nicotine Transdermal Patch for Cannabis Dependence and Nicotine DependenceTreatment
NCT01806779Combination Bupropion / Varenicline for Smoking Cessation in Male SmokersTreatment
NCT01926626Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female SmokersTreatment